Speakers

NHARCON 2018 plenary speakers are global leaders of the HIV scientific community selected from the Word Health Organisation (WHO), the National Institute of Health (NIH) of the United States Department of Health and Human Services, the Centres for Disease Control and Prevention (CDC), Family Health International, Population Council and the School of Public Health, University of Ghana. Speaker’s profiles will be made available in due course.



Topic:
Utilising Differentiated  Models of Care Towards Achieving the 90-90-90 targets – WHO, Geneva

Chairman:
Prof. Isabella A. Quakyi, Co-Chairman, NHARCON 2018

Profile:
Frank J. Lule, WHO Regional Office for Africa.

Frank Lule is the Medical Officer for HIV/AIDS treatment and Viral Hepatitis programme at the World Health Organization’s Regional Office for Africa based in Brazzaville, Congo. The programme is committed to responding to public health challenges of HIV/AIDS and viral hepatitis in all 47 Member States of the African Region. He coordinates the Organization’s HIV treatment programme in the African Region. Dr Lule holds a Medical Degree from Makerere University, Kampala, Uganda and a Masters Degree in Community Health from Trinity College, Dublin, Ireland.

Topic:
Managing and using data in improving targeting and coverage of services in achieving epidemic control- PEPFAR

Chairman:
Prof. Isabella A. Quakyi, Co-Chairman, NHARCON 2018

Profile:

Michael Melchior, PhD, MPH is the acting Ghana Country Director with the Division of Global HIV & TB (DGHT). Dr. Melchior was most recently the Team Lead for the Monitoring & Evaluation (M&E) Strategic Planning team in Atlanta and co-lead for PEPFAR’s interagency Epidemic Control Team focused on TA countries and long-term sustainability. Mike has worked on USAID’s HIV Research team on combination prevention studies, at Peace Corps HQ, as the health sector M&E lead and agency as lead at the Interagency Collaborative for Program Improvement. Mike holds a PhD in Public Health from Florida International University.

 

Topic:
Achieving HIV epidemic control: Optimizing partnerships and synergies between the health facilities and community-based interventions

Chairman:
Dr Emil Asamoah Odae,

Profile:
Dr Anthony Nsia Asare, is a Member of the Volta and a Fellow of Ghana Medical Association. He has about 36 years of work experience as a medical practitioner with over 26 years in management and leadership positions in the healthcare industry. His areas of expertise ranges from Clinical practice in General Surgery, Health System Reforms, Health System Management, and Hospital Management among others. He is currently the Director General of the Ghana Health Service.

Topic:
Evolution and state of ART in  Ghana within the global context

Chairman:
Dr Emil Asamoah Odae,

Profile:
Prof Kwasi Torpey is a Public Health Physician and Associate Professor of Family Health, HIV Clinician, HIV Technical Expert, Program Manager, Researcher, Lecturer and Trainer with extensive experience in implementation of HIV Prevention Care and Treatment, Tuberculosis, Malaria and Non-Communicable Disease programs in Ghana, Nigeria, Kenya, Uganda, Ethiopia, Eritrea, Tanzania, Mozambique, Zimbabwe, Botswana and Zambia as well as  working with USAID, CDC, DFID, World Bank, Global Fund, Ministry of Health and UN donor funded Projects.

Topic:
Immunology of HIV and Vaccine Development

Chairman:
Dr Emil Asamoah Odae,

Profile:

Dr. Morgane Rolland is Chief of the Viral Genetics Section at the US Military HIV Research Program. She received her Ph.D. from the University of Bordeaux, France in 2003. She completed a post-doctoral fellowship with Professor James I. Mullins in the Microbiology department of the University of Washington in Seattle between 2004 and 2010. Dr. Rolland’s research has focused on understanding features of HIV-1 genetics and evolution that are important to HIV vaccine-related research. She was involved in the design of HIV-1 vaccine candidates based on an evolutionary-specified ancestor of HIV (Rolland et al., JVI, 2007) and on ‘Conserved Elements’ of the HIV-1 proteome (Rolland et al., PLoS Pathogens, 2007). She has led sieve analyses of HIV-1 breakthrough infections showing for the first time that vaccines could have a genetic impact on viruses found in vaccine recipients (Rolland et al., Nature Medicine, 2011; Rolland et al., Nature, 2012). More recently, Dr. Rolland’s lab has been developing a systems serology platform to analyze Fc-mediated antibody functions.

Topic:
HIV Vaccines: Immunology Designs for the induction of anti-HIV immune responses.

Chairman:
Dr Emil Asamoah Odae

Profile:

Director
AIDS Research Center, National Institute of Infectious Diseases (NIID), Japan
http://www0.nih.go.jp/niid/ARC/index-en.html

Professor
Institute of Medical Science, University of Tokyo, Japan
http://square.umin.ac.jp/arc/en/Matano_Research_Group_EN/Home.html

Tetsuro Matano obtained MD at Faculty of Medicine, University of Tokyo in 1985, and worked as an Orthopaedic Surgeon for five years. He obtained PhD (Doctor of Medical Science) at Graduate School of Medicine, University of Tokyo in 1994. He started his study on AIDS pathogenesis using monkey AIDS models at NIAID, NIH, and presented crucial evidence indicating the importance of cytotoxic T lymphocyte (CTL) responses in immunodeficiency virus control. He has been a Professor at Institute of Medical Science, University of Tokyo since 2006 and the Director at AIDS Research Center, National Institute of Infectious Diseases since 2010. He has been working on the immune mechanism for HIV/SIV control in a unique AIDS model using MHC-defined Burmese rhesus macaques and developed a novel CTL-based AIDS vaccine system using Sendai viral vectors whose clinical trial phase I has been conducted at Rwanda, Kenya and UK in collaboration with International AIDS Vaccine Initiative and ID Pharma.


Topic:
Moments in public health: Lessons from the global HIV response to achieve epidemic control

Chairman:
Dr Anthony Nsia Asare, Director General, Ghana Health Service

Profile:
Professor Peter R. Lamptey is a public health physician and expert on health and development in developing countries, with particular expertise in Communicable and Non-communicable diseases (NCD). He is currently a Professor of non-communicable diseases at the London School of Hygiene and Tropical Medicine, and also President Emeritus and Distinguished Scientist at FHI360. He has over 36 years career at FHI 360 and is a member of the Lancet Commission on Future Health of Sub-Saharan Africa.

Topic:
Leaving No One Behind: Rethinking accelerated comprehensive prevention and treatment for Key Populations  and young people

Chairman:
Dr Anthony Nsia Asare, Director General, Ghana Health Service

Profile:
Kent Klindera, MPH, has over 25 years of experience on health and human rights programming, with a concentration on sexual health for youth and key populations.  Currently, based in Washington DC, he serves as a Senior Technical Advisor at USAID/Office of HIV/AIDS, supporting USAID missions to implement innovative cost-effective KP-specific programs, and decrease of stigma, discrimination and violence targeted at key populations (KP) and people living with HIV.

Topic:
Making a case for socio-cultural, ethical and human rights aspects of the national HIV response

Chairman:
Dr Anthony Nsia Asare, Director General, Ghana Health Service

Profile:
Amos Laar, Ph.D
, is a Senior Lecturer of the University of Ghana with academic training in Nutrition, Public Health, and Bioethics. Dr. Laar has written and presented extensively on maternal and young child nutrition, nutrition-related non-communicable diseases (NR-NCDs), as well as Reproductive Health. He has served as a consultant to international organizations, national governments, and non-governmental organizations. He has also worked on several projects on HIV/AIDS in which he led such projects as the “Non-prescription Medication Use Project” (which assessed multiple non-prescription medications use among Ghanaian HIV-positive persons on antiretroviral therapy).